Drug Profile
Research programme: Chagas disease vaccines - Gador/SEEK
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator PepTcell
- Developer SEEK
- Class Vaccines
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chagas disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Chagas'-disease in United Kingdom (Parenteral)
- 20 Oct 2009 Development is ongoing in the UK
- 17 Dec 2007 Early research in Chagas' disease in United Kingdom (unspecified route)